AbbVie Inc. (TSX:ABBV)
Canada · Delayed Price · Currency is CAD 40.81
+0.57 (1.42%)
Oct 30, 2026, 3:50 PM EDT
AbbVie Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 727,088 | 553,699 | 451,826 | 361,331 | 386,682 | 302,922 | |
Market Cap Growth | 31.57% | 22.55% | 25.05% | -6.56% | 27.65% | 25.67% |
Enterprise Value | 816,892 | 640,383 | 544,022 | 424,625 | 465,385 | 389,627 |
Last Close Price | 40.81 | 31.22 | 23.90 | 20.56 | 21.64 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 50.77 | 96.47 | 74.10 | 56.77 | 24.25 | 20.87 |
PS Ratio | 7.76 | 6.60 | 5.57 | 5.04 | 4.92 | 4.26 |
PB Ratio | - | -125.10 | 93.35 | 26.32 | 16.53 | 15.51 |
P/FCF Ratio | 28.57 | 22.67 | 17.61 | 12.40 | 11.78 | 10.89 |
P/OCF Ratio | 26.67 | 21.22 | 16.70 | 11.98 | 11.45 | 10.51 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.87 | 7.64 | 6.71 | 5.92 | 5.92 | 5.48 |
EV/EBITDA Ratio | 18.24 | 15.97 | 14.65 | 11.95 | 11.98 | 10.89 |
EV/EBIT Ratio | 24.32 | 22.12 | 21.70 | 17.65 | 17.00 | 15.58 |
EV/FCF Ratio | 32.10 | 26.22 | 21.20 | 14.57 | 14.18 | 14.00 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -12.04 | -21.19 | 20.29 | 5.83 | 3.74 | 5.03 |
Debt / EBITDA Ratio | 2.21 | 2.31 | 2.61 | 2.23 | 2.22 | 2.71 |
Debt / FCF Ratio | - | 3.84 | 3.83 | 2.75 | 2.66 | 3.53 |
Net Debt / Equity Ratio | -10.92 | -19.56 | 18.64 | 4.59 | 3.20 | 4.39 |
Net Debt / EBITDA Ratio | 2.03 | 2.16 | 2.43 | 1.78 | 1.93 | 2.40 |
Net Debt / FCF Ratio | - | 3.54 | 3.52 | 2.17 | 2.28 | 3.08 |
Asset Turnover | - | 0.46 | 0.42 | 0.40 | 0.41 | 0.38 |
Inventory Turnover | - | 3.80 | 4.03 | 4.38 | 4.93 | 5.38 |
Quick Ratio | - | 0.41 | 0.43 | 0.63 | 0.69 | 0.56 |
Current Ratio | - | 0.67 | 0.66 | 0.87 | 0.96 | 0.79 |
Return on Equity (ROE) | - | 6225.00% | 62.29% | 35.20% | 72.40% | 80.95% |
Return on Assets (ROA) | - | 9.81% | 8.07% | 8.32% | 8.86% | 8.31% |
Return on Invested Capital (ROIC) | - | 17.29% | 28.05% | 21.71% | 22.82% | 20.09% |
Return on Capital Employed (ROCE) | - | 23.30% | 18.10% | 18.80% | 18.50% | 17.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.97% | 1.05% | 1.36% | 1.78% | 4.14% | 4.82% |
FCF Yield | 3.50% | 4.41% | 5.68% | 8.06% | 8.49% | 9.19% |
Dividend Yield | 2.94% | 2.91% | 3.54% | 3.87% | 3.54% | 3.92% |
Payout Ratio | 149.27% | 275.84% | 257.71% | 216.72% | 84.85% | 80.24% |
Buyback Yield / Dilution | - | - | -0.06% | 0.28% | -0.06% | -6.22% |
Total Shareholder Return | 2.94% | 2.91% | 3.48% | 4.15% | 3.48% | -2.29% |